Xinjiang Communications Construction Group and New World Strategic Investment both contributed to a $21.4m round for the satellite system developer.

Columbia University’s Vor Biopharma has collected more capital from shareholders including Osage University Partners, Johnson & Johnson and PureTech Health.

Financial integration platform developer Flinks closed a series A round led by existing investor National Bank through its NAventures subsidiary.

The finance management software developer raised $28.5m in its third round in the past year, to increase its overall funding to $85m.

Delivery robot developer Pudu Robotics received a series B investment by the mobile services platform in connection with a strategic partnership.

Pfizer Ventures joined Mission’s other existing investors to push the mitochondria-focused drug developer’s lifetime funding to approximately $143m.

UCSF has unveiled Nine Square Therapeutics with $50m in series A capital from founding investor Apple Tree Partners.

The ultrasound therapeutics developer, a University of Oxford spinout, has raised series B2 funding in the run-up to clinical testing of its cancer drug delivery platform.

Pfizer Ventures joined Mission’s other existing investors to push the mitochondria-focused drug developer’s lifetime funding to approximately $143m.

The GLP-backed international logistics provider raised $71.1m in a Taikang-led round that will support a global expansion.